Trexapharm exists to close the gap between clinical need and clinical access — by developing therapies that are scientifically sound, practically delivered, and purpose-built for real-world impact.
Built on the principle that innovation should improve lives now — not years from now — Trexapharm combines repurposed compounds, precision delivery, and regulatory access to create treatment options for people failed by the standard system.
Our lead therapy is already in clinical use — offering an evidence-backed, dual-mechanism alternative for people with treatment-resistant depression, including eligible veterans under DVA funding.
Our lead therapy is already in clinical use — offering an evidence-backed, dual-mechanism alternative for people with treatment-resistant depression, including eligible veterans under DVA funding.
>>
Safer, scalable therapies that integrate with real-world practice
DVA-funded access for eligible patients
A new path forward, with care that works in the real world
Repurposed innovation, regulatory momentum, near-term impact
Explore information tailored to your needs — whether you’re a clinician, patient, or investor.
>>
Clinical use, mechanisms, evidence, prescribing
guidance
>>
What TREXAVIVE is, how it works, where to ask
>>
Eligibility, DVA access, peer networks
>>
Opportunity, science, momentum
>>
Beyond TREXAVIVE — our development strategy
>>
General, partnerships, media